Related Experiment Video
Updated: Feb 7, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Mechanisms of Complement-Mediated Damage in Hematological Disorders
Ronald P Taylor1, Margaret A Lindorfer1
1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA.
Defects in complement regulation cause hemolytic diseases like paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Understanding complement activation is key to treating these conditions.
Area of Science:
- Immunology
- Hematology
Background:
- The complement cascade is a crucial innate immune defense system.
- Proper regulation prevents damage to host cells and tissues.
- Dysregulation is implicated in various pathological conditions.
Purpose of the Study:
- To discuss the pathogenic mechanisms of complement-mediated hemolytic diseases.
- To emphasize the pivotal steps in complement activation in disease.
- To highlight the role of complement in erythrocyte destruction.
Main Methods:
- Review of literature on complement system function and regulation.
- Analysis of pathogenic mechanisms in specific hemolytic diseases.
- Focus on complement activation pathways.
Main Results:
- Defects in complement regulation (mutations, autoantibodies) cause hemolytic diseases.
- Complement activation is central to paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
- Antierythrocyte antibodies utilize complement for erythrocyte destruction in autoimmune hemolytic anemias.
Conclusions:
- Complement dysregulation is a significant factor in hemolytic disease pathogenesis.
- Targeting complement activation pathways offers therapeutic potential.
- Further understanding of complement control is vital for clinical applications.
Related Concept Videos
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Intrinsically Disordered Proteins
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Receptor-mediated Endocytosis

